• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    6/14/24 2:13:08 PM ET
    $ADBE
    $ATI
    $BAND
    $BE
    Computer Software: Prepackaged Software
    Technology
    Steel/Iron Ore
    Industrials
    Get the next $ADBE alert in real time by email

    Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results.

    AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for a loss of 1 cent per share. The company reported quarterly sales of $40.42 million topping estimates of $37.90 million, according to data from Benzinga Pro.

    AMMO shares dipped 19.1% to $2.0306 on Friday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) shares jumped 345% to $6.06.
    • SRIVARU Holding Limited (NASDAQ:SVMH) gained 150% to $0.3852 after the company announced it will begin accepting paid reservations and bookings for its flagship product, the PRANA 2.0, on June 16th.
    • CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) surged 42.5% to $5.16.
    • FOXO Technologies Inc. (NASDAQ:FOXO) shares gained 29% to $0.3092 after the company announced it entered into share exchange agreements with Rennova Health.
    • Jeffs’ Brands Ltd (NASDAQ:JFBR) surged 29% to $0.4528.
    • BIMI Holdings Inc. (NASDAQ:BIMI) gained 25.7% to $2.15.
    • Longeveron Inc. (NASDAQ:LGVN) rose 23.4% to $3.36.
    • OneMedNet Corporation (NASDAQ:ONMD) gained 20% to $1.4599 as the company announced iRWD customer data license agreement with a leading U.S.-based global clinical trial design and software company.
    • Can-Fite BioPharma Ltd. (NYSE:CANF) jumped 17.9% to $4.28.
    • Disc Medicine, Inc. (NASDAQ:IRON) rose 15.6% to $45.29. Disc Medicine announced a $178 million underwritten offering of 4.944 million shares at $36 per share.
    • Adobe Inc. (NASDAQ:ADBE) rose gained 14.3% to $524.39 following better-than-expected second-quarter earnings and strong guidance.
    • RenovoRx, Inc. (NASDAQ:RNXT) surged 14.3% to $1.2001.
    • Ocular Therapeutix, Inc. (NASDAQ:OCUL) gained 14.1% to $5.75 as the company highlighted AXPAXLI SOL-1 enrollment and plans repeat dosing study in wet AMD.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) gained 14% to $0.1836 after dipping 17% on Thursday.
    • VinFast Auto Ltd. (NASDAQ:VFS) gained 9.9% to $4.32. VinFast Auto anticipates sustained growth for next five years and approaching break-even point.
    • Tutor Perini Corporation (NYSE:TPC) rose 9.9% to $21.11. UBS analyst Steven Fisher upgraded Tutor Perini from Neutral to Buy and raised the price target from $14 to $27.
    • Willis Lease Finance Corporation (NASDAQ:WLFC) gained 6.4% to $64.99.
    • Hasbro, Inc. (NASDAQ:HAS) gained 5.5% to $61.22 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $70 to $80.

    Losers

    • QXO, Inc. (NASDAQ:QXO) shares dipped 43.3% to $116.47 after announcing a $3.5 billion private placement.
    • Nexalin Technology, Inc. (NASDAQ:NXL) shares fell 33.3% to $0.9192 after jumping 121% on Thursday. Nexalin Technology recently announced regulatory approval of Gen-2 15mA neurostimulation device by Brazilian Health Regulatory Agency.
    • IN8bio, Inc. (NASDAQ:INAB) dipped 31.1% to $1.1598 after the company presented data from its Phase 1 trial of INB-100 showing 100% of treated leukemia patients achieved durable complete remission at 1 year.
    • Gain Therapeutics, Inc. (NASDAQ:GANX) fell 28.1% to $1.3599 after the company announced the pricing of a $11 million public offering of 7,116,547 shares at $1.35 per share and pre-funded warrants.
    • Kyverna Therapeutics, Inc. (NASDAQ:KYTX) dipped 24.8% to $10.88.
    • Rezolute, Inc. (NASDAQ:RZLT) shares fell 24.3% to $3.90 after the company announced pricing of public offering of $60 million of common stock and pre-funded warrants.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) dipped 20.2% to $0.3302.
    • NaaS Technology Inc. (NASDAQ:NAAS) fell 20.2% to $5.66. The company announced completion of ADS ratio change.
    • NanoViricides, Inc. (NASDAQ:NNVC) fell 19.3% to $2.08
    • Neo-Concept International Group Holdings Limited (NASDAQ:NCI) shares fell 19.2% to $0.7141 after jumping over 35% on Thursday.
    • Ostin Technology Group Co Ltd (NASDAQ:OST) fell 19.2% to $0.4020 after jumping 24% on Thursday.
    • RH (NYSE:RH) shares fell 18.6% to $225.60 after the company reported mixed first-quarter financial results.
    • Assure Holdings Corp. (NASDAQ:IONM) declined 15.3% to $0.26.
    • Bandwidth Inc. (NASDAQ:BAND) fell 13.1% to $16.07. Morgan Stanley analyst Meta Marshall downgraded Bandwidth from Equal-Weight to Underweight and lowered the price target from $18 to $15.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) dipped 12.5% to $10.99 as the company announced initial clinical data from Phase 1/2 RESET-Myositis and RESET-SLE trials of CABA-201.
    • 2U, Inc. (NASDAQ:TWOU) fell 10.5% to $6.11.
    • Corcept Therapeutics Incorporated (NASDAQ:CORT) dipped 10% to $28.36.
    • Novavax, Inc. (NASDAQ:NVAX) fell 9.7% to $13.59.
    • PENN Entertainment, Inc. (NASDAQ:PENN) fell 9.6% to $17.23. Truist Securities analyst Barry Jonas maintained PENN Entertainment with a Buy and raised the price target from $23 to $25.
    • ATI Inc. (NYSE:ATI) fell 9.6% to $51.65.
    • MSC Industrial Direct Co., Inc. (NYSE:MSM) shares declined 8.3% to $77.48 after the company reported preliminary third-quarter financial results below estimates and cut its FY24 adjusted operating margin.
    • Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell 7.7% to $39.82 as the company announced the pricing of public offering of common stock and pre-funded warrants.
    • WESCO International, Inc. (NYSE:WCC) fell 7.1% to $161.79.
    • Carnival plc (NYSE:CUK) fell 6.7% to $13.89.
    • Bloom Energy Corporation (NYSE:BE) fell 5.7% to $14.23.
    • Telephone and Data Systems, Inc. (NYSE:TDS) fell 5.6% to $18.93

    Now Read This: Dell, Palo Alto Networks And 2 Other Stocks Insiders Are Selling

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $ATI
    $BAND
    $BE

    CompanyDatePrice TargetRatingAnalyst
    Hasbro Inc.
    $HAS
    2/25/2026$118.00Outperform
    BNP Paribas Exane
    Bloom Energy Corporation
    $BE
    2/24/2026$162.00Neutral
    Citigroup
    Bloom Energy Corporation
    $BE
    2/6/2026$105.00 → $160.00Hold
    TD Cowen
    MSC Industrial Direct Company Inc.
    $MSM
    2/6/2026$95.00Overweight → Neutral
    Analyst
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Bloom Energy Corporation
    $BE
    1/28/2026$153.00Equal Weight
    Barclays
    Bloom Energy Corporation
    $BE
    1/28/2026$207.00Buy
    China Renaissance
    Bandwidth Inc.
    $BAND
    1/23/2026$20.00Buy
    B. Riley Securities
    More analyst ratings

    $ADBE
    $ATI
    $BAND
    $BE
    SEC Filings

    View All

    SEC Form S-8 filed by Nauticus Robotics Inc.

    S-8 - Nauticus Robotics, Inc. (0001849820) (Filer)

    3/4/26 4:05:46 PM ET
    $KITT
    Industrial Machinery/Components
    Industrials

    SEC Form 6-K filed by Can-Fite Biopharma Ltd

    6-K - Can-Fite BioPharma Ltd. (0001536196) (Filer)

    3/4/26 7:05:05 AM ET
    $CANF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Bandwidth Inc.

    144 - Bandwidth Inc. (0001514416) (Subject)

    3/3/26 5:59:27 PM ET
    $BAND
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $ATI
    $BAND
    $BE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BNP Paribas Exane initiated coverage on Hasbro with a new price target

    BNP Paribas Exane initiated coverage of Hasbro with a rating of Outperform and set a new price target of $118.00

    2/25/26 8:51:16 AM ET
    $HAS
    Recreational Games/Products/Toys
    Consumer Discretionary

    Citigroup initiated coverage on Bloom Energy with a new price target

    Citigroup initiated coverage of Bloom Energy with a rating of Neutral and set a new price target of $162.00

    2/24/26 7:46:09 AM ET
    $BE
    Industrial Machinery/Components
    Energy

    TD Cowen reiterated coverage on Bloom Energy with a new price target

    TD Cowen reiterated coverage of Bloom Energy with a rating of Hold and set a new price target of $160.00 from $105.00 previously

    2/6/26 8:24:09 AM ET
    $BE
    Industrial Machinery/Components
    Energy

    $ADBE
    $ATI
    $BAND
    $BE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SEABOURN INTRODUCES "YOURS TO EXPLORE EVENT," OFFERING SUITE UPGRADES AND SHIPBOARD CREDIT ON SELECT 2026 AND BEYOND VOYAGES

    Complimentary Two-Category Veranda Suite Upgrades and Shipboard Credit Available on More than 500 Ocean and Expedition Sailings Booked Through May 5, 2026SEATTLE, March 4, 2026 /PRNewswire/ -- Seabourn, the leader in luxury and expedition travel, invites travelers to embrace a world of curated luxury with its new "Yours to Explore Event." Available now through May 5, 2026, the promotion will offer a complimentary two-category Veranda Suite upgrade and shipboard credit for guests booking select 2026 and beyond ocean and expedition voyages. Benefits for the "Yours to Explore Event

    3/4/26 3:52:00 PM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds

    RAMAT GAN, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF) ("Can-Fite" or the "Company"), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 795,869 American Depositary Shares (ADSs), having an exercise price of $9.34 per ADS, issued by Can-Fite in July 2025, at a reduced exercise price of $5.00 per ADS. The ADSs representing ordinary shares issuable upon exercise of the warrants are registered pursuant to an effective regi

    3/4/26 10:25:41 AM ET
    $CANF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Willis Lease Finance Corporation Welcomes Marilyn Gan as Head of Origination, Asia Pacific

    COCONUT CREEK, Fla., March 04, 2026 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ:WLFC) ("WLFC" or the "Company"), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced the appointment of Marilyn Gan as Head of Origination, Asia Pacific. In this role, Marilyn will lead origination efforts in Asia for WLFC's owned portfolio as well as for funds managed by the Company's recently announced asset manager, Willis Aviation Capital, leveraging her extensive experience in structuring debt and equity transactions and building strategic partnerships across the aviation industry. Most recently, Marilyn served as Head of Asia Paci

    3/4/26 10:08:16 AM ET
    $WLFC
    Industrial Specialties
    Consumer Discretionary

    $ADBE
    $ATI
    $BAND
    $BE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    October 3, 2023 - FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants

    For Immediate Release: October 03, 2023 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. Individuals 12 years of age and older previously vaccinated with a COVID-19 vaccine (and who have not already been vaccinated with a recently updated mRNA CO

    10/3/23 2:56:27 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ADBE
    $ATI
    $BAND
    $BE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Miller Andrew Craig

    3 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)

    3/4/26 4:30:07 PM ET
    $KYTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Miller Andrew Craig was granted 11,006 shares (SEC Form 4)

    4 - Kyverna Therapeutics, Inc. (0001994702) (Issuer)

    3/4/26 4:30:04 PM ET
    $KYTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Executive Officer Willis Austin Chandler sold $666,070 worth of shares (3,400 units at $195.90), decreasing direct ownership by 2% to 181,346 units (SEC Form 4)

    4 - WILLIS LEASE FINANCE CORP (0001018164) (Issuer)

    3/4/26 4:15:40 PM ET
    $WLFC
    Industrial Specialties
    Consumer Discretionary

    $ADBE
    $ATI
    $BAND
    $BE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Scaccetti Jane bought $120,720 worth of shares (8,000 units at $15.09), increasing direct ownership by 7% to 117,153 units (SEC Form 4)

    4 - PENN Entertainment, Inc. (0000921738) (Issuer)

    3/3/26 8:30:03 AM ET
    $PENN
    Hotels/Resorts
    Consumer Discretionary

    Director Lindstrom Richard L Md bought $461,354 worth of shares (60,229 units at $7.66), increasing direct ownership by 32% to 246,933 units (SEC Form 4)

    4 - OCULAR THERAPEUTIX, INC (0001393434) (Issuer)

    2/24/26 6:13:03 PM ET
    $OCUL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Medical Officer Agah Ramtin bought $9,975 worth of shares (10,000 units at $1.00), increasing direct ownership by 1% to 798,460 units (SEC Form 4)

    4 - RenovoRx, Inc. (0001574094) (Issuer)

    1/22/26 7:00:18 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $ATI
    $BAND
    $BE
    Leadership Updates

    Live Leadership Updates

    View All

    Willis Lease Finance Corporation Welcomes Marilyn Gan as Head of Origination, Asia Pacific

    COCONUT CREEK, Fla., March 04, 2026 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ:WLFC) ("WLFC" or the "Company"), the leading lessor of commercial aircraft engines and a global provider of aviation services, today announced the appointment of Marilyn Gan as Head of Origination, Asia Pacific. In this role, Marilyn will lead origination efforts in Asia for WLFC's owned portfolio as well as for funds managed by the Company's recently announced asset manager, Willis Aviation Capital, leveraging her extensive experience in structuring debt and equity transactions and building strategic partnerships across the aviation industry. Most recently, Marilyn served as Head of Asia Paci

    3/4/26 10:08:16 AM ET
    $WLFC
    Industrial Specialties
    Consumer Discretionary

    RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum

    Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared Device Over 700 RenovoCath Procedures Successfully Completed Since FDA Clearance in 2014 Company Appoints Ramtin Agah, MD to the Additional Position of Executive Chairman to Support Continued Clinical Adoption and Commercial Growth MOUNTAIN VIEW, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or "the Company") (NASDAQ:RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a patented, FDA-cleared drug-delivery device, today announced continued commercial progress, with

    2/27/26 8:30:00 AM ET
    $RNXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors

    Sravan Emany brings capital markets and commercial-stage, rare disease expertise as the Company advances towards commercialization Andrew Miller adds deep clinical development and product approval experience to support Kyverna's next phase of growth EMERYVILLE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ:KYTX), a clinical-stage biopharmaceutical company developing cell therapies for patients with autoimmune diseases, today announced the appointments of Sravan K. Emany and Andrew Miller, Ph.D. to its Board of Directors. Mr. Emany will assume the role of Audit Committee Chair, following the transition of Dan Spiegelman from this position, who has stepped d

    2/24/26 8:00:00 AM ET
    $KYTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADBE
    $ATI
    $BAND
    $BE
    Financials

    Live finance-specific insights

    View All

    Adobe to Announce Q1 FY2026 Earnings Results on March 12, 2026

    Today, Adobe (NASDAQ:ADBE), the global technology leader that unleashes creativity, productivity and customer experiences through innovative tools and platforms, announced it will release its first quarter fiscal year 2026 results after the market closes on Thursday, March 12, 2026, followed by a conference call with investors from 2-3 p.m. Pacific Time. The conference call will be streamed live on the Adobe Investor Relations Site. Following the call, a recording and related materials will be available on the site. Adobe uses its website as a channel of distribution of material company information. Financial, product and other material information regarding the company is routinely poste

    3/2/26 1:00:00 PM ET
    $ADBE
    Computer Software: Prepackaged Software
    Technology

    Wesco Declares Quarterly Dividend on Common Stock

    PITTSBURGH, Feb. 26, 2026 /PRNewswire/ -- The Board of Directors of Wesco International (NYSE:WCC) today declared a quarterly cash dividend on all of the issued and outstanding shares of common stock, in an amount equal to $0.50 per share. The dividend is payable on March 31, 2026 to the holders of record of the common stock at the close of business on March 13, 2026. About Wesco Wesco International (NYSE:WCC) builds, connects, powers and protects the world. Headquartered in Pittsburgh, Pennsylvania, Wesco is a FORTUNE 500® company with approximately $24 billion in annual sales

    2/26/26 4:45:00 PM ET
    $WCC
    Telecommunications Equipment
    Consumer Discretionary

    Tutor Perini Declares Quarterly Dividend

    Tutor Perini Corporation (NYSE:TPC), a leading civil, building and specialty construction company, announced today that its Board of Directors has declared a quarterly cash dividend in the amount of $0.06 per share of Tutor Perini common stock payable on March 26, 2026, to shareholders of record as of the close of business on March 10, 2026. About Tutor Perini Corporation Tutor Perini Corporation is a leading civil, building and specialty construction company offering diversified general contracting and design-build services to private customers and public agencies throughout the world. We have provided construction services since 1894 and have established a strong reputation within our

    2/26/26 4:16:00 PM ET
    $TPC
    General Bldg Contractors - Nonresidential Bldgs
    Consumer Discretionary

    $ADBE
    $ATI
    $BAND
    $BE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Kaival Brands Innovations Group Inc.

    SC 13D/A - Kaival Brands Innovations Group, Inc. (0001762239) (Subject)

    12/12/24 7:22:30 PM ET
    $KAVL
    Other Consumer Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/6/24 4:05:57 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cabaletta Bio Inc.

    SC 13G/A - Cabaletta Bio, Inc. (0001759138) (Subject)

    12/5/24 4:50:19 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care